Showing results (1271-1280 of 2,357) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|June 1, 1994
Plasma HVA levels following debrisoquine administration do not reflect cerebral dopamine loss in early Parkinson's diseaseS Rose, J G Hindmarsh, M J Steiger, et al.Clinical Neuropharmacology|June 1, 1994
Severe central nervous system toxicity after chronic treatment with cyclosporineM García-Escrig, J Martinez, J Fernandez-Ponsatí, et al.Clinical Neuropharmacology|August 1, 1994
Dystonic storms: a practical management problemJ Vaamonde, J Narbona, R Weiser, et al.Clinical Neuropharmacology|August 1, 1994
Acute and delayed cerebral infarction after wasp sting anaphylaxisJ E Riggs, L M Ketonen, J P Wymer, et al.Clinical Neuropharmacology|October 1, 1994
Felbamate pharmacology and use in epilepsyD E Burdette, J C SackellaresClinical Neuropharmacology|October 1, 1994
Controlled release levodopa/carbidopa 25/100 (Sinemet CR 25/100): pharmacokinetics and clinical efficacy in untreated parkinsonian patientsJ P Hammerstad, W R Woodward, J G Nutt, et al.Clinical Neuropharmacology|October 23, 1997
Side effects of high-dose intravenous immunoglobulinsM Stangel, H P Hartung, P Marx, et al.Clinical Neuropharmacology|October 23, 1997
Reduction of aggressiveness and impulsiveness during clozapine treatment in chronic neuroleptic-resistant schizophrenic patientsB Spivak, R Mester, N Wittenberg, et al.Clinical Neuropharmacology|May 14, 1998
A review of the randomized controlled trials of tacrine in the treatment of Alzheimer's disease: methodologic considerationsE L ConwayClinical Neuropharmacology|May 14, 1998
Lamotrigine add-on therapy in focal epilepsy: electroencephalographic and neuropsychological evaluationM G Marciani, P Stanzione, D Mattia, et al.Pageof 236